PD-L1 blockadeatezolizumabbevacizumabatezolizumab-containingHigh-grade serous ovarian canceraspirinPROCEORTC-1508GCGlow-dose aspirinplatinum-resistant ovarian cancer+1 more
…ing the tumor endothelial barrier, potentially synergizing with PD-L1 blockade. The EORTC-1508GCG phase II trial evaluated atezolizumab (anti-…